Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,473 | 42,132 | 47,998 | 53,391 | 59,928 |
| TOTAL | $37,740 | $43,261 | $49,381 | $54,366 | $61,029 |
| Non-Current Assets | |||||
| PPE Net | 700 | 268 | 295 | 226 | 271 |
| Other Non-Current Assets | 1,717 | 1,909 | 2,099 | 1,559 | 1,717 |
| TOTAL | $2,417 | $2,177 | $2,394 | $1,785 | $1,988 |
| Total Assets | $40,157 | $45,438 | $51,775 | $56,151 | $63,017 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,514 | 6,615 | 7,247 | 6,224 | 7,714 |
| TOTAL | $9,260 | $7,349 | $7,969 | $6,834 | $8,314 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 595 | 785 | 972 | 531 | 685 |
| TOTAL | $595 | $35,785 | $35,972 | $35,533 | $35,690 |
| Total Liabilities | $9,855 | $43,134 | $43,941 | $42,367 | $44,004 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,441 | 31,375 | 31,375 | 31,196 | 31,196 |
| Common Shares | 31 | 31 | 31 | 31 | 31 |
| Retained earnings | -387,334 | -415,235 | -409,713 | -403,773 | -398,642 |
| Other shareholders' equity | -60 | -39 | -20 | 0 | 0 |
| TOTAL | $30,302 | $2,304 | $7,834 | $13,784 | $19,013 |
| Total Liabilities And Equity | $40,157 | $45,438 | $51,775 | $56,151 | $63,017 |